ARCHIVES

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Smoking Cessation Training Follows Doctors Into Practice

October 29, 2004

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

New Treatment Approach To Treating Brain Tumor

April 26, 2002

CCOP RFA Due In Mid-July; DCT Board Gives Its Concept Approval

June 11, 1982

Big Community Programs Under Way In Detroit, N.M.; Others Near OK

January 14, 1977

Construction Funds Far Short Of NCA request; Terry Sees No Improvement

October 3, 1980